Multifunctional nanoparticles for cancer immunotherapy

Human Vaccines & Immunotherapeutics
Tayebeh Saleh, Seyed Abbas Shojaosadati

Abstract

During the last decades significant progress has been made in the field of cancer immunotherapy. However, cancer vaccines have not been successful in clinical trials due to poor immunogenicity of antigen, limitations of safety associated with traditional systemic delivery as well as the complex regulation of the immune system in tumor microenvironment. In recent years, nanotechnology-based delivery systems have attracted great interest in the field of immunotherapy since they provide new opportunities to fight the cancer. In particular, for delivery of cancer vaccines, multifunctional nanoparticles present many advantages such as targeted delivery to immune cells, co-delivery of therapeutic agents, reduced adverse outcomes, blocked immune checkpoint molecules, and amplify immune activation via the use of stimuli-responsive or immunostimulatory materials. In this review article, we highlight recent progress and future promise of multifunctional nanoparticles that have been applied to enhance the efficiency of cancer vaccines.

References

Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·A F OchsenbeinR M Zinkernagel
Jan 18, 2003·Science·Chandrashekhar Pasare, Ruslan Medzhitov
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julia A BrownGordon J Freeman
Apr 30, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·John DileoLeaf Huang
Jul 26, 2003·Seminars in Oncology·Edgar G Engleman
Jun 3, 2004·The Journal of Clinical Investigation·Jay A BerzofskyJohn C Morris
Jul 13, 2004·Science·Joseph N Blattman, Philip D Greenberg
Aug 17, 2004·Immunity·Gavin P DunnRobert D Schreiber
Oct 7, 2004·The American Journal of Pathology·Anil K SoodMary J C Hendrix
Jan 26, 2005·Endocrine Research·Margery A Connelly, David L Williams
Feb 3, 2005·Nature Reviews. Drug Discovery·Vladimir P Torchilin
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Young Jik KwonJean M J Fréchet
Mar 15, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sai T ReddyMelody A Swartz
Aug 8, 2006·Biotechnology Journal·Manfred SchusterRalf Kircheis
Aug 18, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jyotsnabaran HalderAnil K Sood
Oct 20, 2006·Trends in Immunology·Sai T ReddyJeffrey A Hubbell
Dec 23, 2006·Nature Reviews. Immunology·Hua YuDrew Pardoll
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Junzo HamanishiShingo Fujii
Apr 6, 2007·The AAPS Journal·Molly E Martin, Kevin G Rice
Aug 9, 2007·Advanced Drug Delivery Reviews·Jaspreet K Vasir, Vinod Labhasetwar
Sep 18, 2007·Nature Biotechnology·Sai T ReddyJeffrey A Hubbell
Jan 26, 2008·Nature Reviews. Cancer·Jason RiceFreda K Stevenson
Feb 29, 2008·Journal of Neuroimmunology·Thomas SchneiderBernhard A Sabel
Apr 18, 2008·Nature Reviews. Cancer·Cornelis J M Melief, Sjoerd H van der Burg
Sep 2, 2008·Nature Reviews. Drug Discovery·Mark E DavisDong M Shin
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Jun 13, 2009·Current Pharmaceutical Design·Marc Beyer, Joachim L Schultze
Sep 11, 2009·Journal of Leukocyte Biology·G SolinasP Allavena
Sep 29, 2009·Colloids and Surfaces. B, Biointerfaces·Avnesh KumariSubhash C Yadav
Jan 19, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hidetaka AkitaHideyoshi Harashima
Apr 14, 2010·Cell Biology International·Sujit K BhutiaTapas K Maiti
Aug 20, 2010·Pharmaceutical Research·Yogita KrishnamachariAliasger K Salem
Sep 9, 2010·Expert Review of Vaccines·Moses O OyewumiZhengrong Cui
Sep 21, 2010·European Journal of Immunology·Gerold Schuler
Dec 25, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Xinran LiZhengrong Cui
Feb 19, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Alina ShapiraYehuda G Assaraf
Apr 8, 2011·Neoplasia : an International Journal for Oncology Research·Mian M K ShahzadAnil K Sood
Jun 18, 2011·Advanced Drug Delivery Reviews·Samar HamdyAfsaneh Lavasanifar

❮ Previous
Next ❯

Citations

May 8, 2020·Journal of Immunology Research·Manal Ali BuabeidGhulam Murtaza
Sep 3, 2020·Nanomaterials·Sarkar Siddique, James C L Chow
Sep 13, 2020·Cells·Simone HagerMatthias Bros
Apr 2, 2021·International Journal of Nanomedicine·Tobias Achu MuluhJingBo Wu
Sep 29, 2017·Bioconjugate Chemistry·Hamilton KakwereKatherine W Ferrara

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection

Software Mentioned

MENDhydo

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.